Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Ticker Scorecard - EBS

Basics
Company: Emergent Biosolutions, Inc.
IPO Date: December 1, 2006
Sector: Healthcare
Industry: Biotech
Market Cap: $541.84M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.59 | 2.25%
Avg Daily Range (30 D): $0.24 | 2.46%
Avg Daily Range (90 D): $0.31 | 3.29%
Institutional Daily Volume
Avg Daily Volume: .52M
Avg Daily Volume (30 D): .8M
Avg Daily Volume (90 D): 1.08M
Trade Size
Avg Trade Size (Sh.): 112
Avg Trade Size (Sh.) (30 D): 95
Avg Trade Size (Sh.) (90 D): 109
Institutional Trades
Total Inst.Trades: 4,774
Avg Inst. Trade: $2.56M
Avg Inst. Trade (30 D): $1.25M
Avg Inst. Trade (90 D): $1.13M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.35M
Avg Closing Trade (30 D): $1.2M
Avg Closing Trade (90 D): $1.11M
Avg Closing Volume: 105.11K
   
News
Jan 16, 2025 @ 1:00 PM
Enrollment Starts in Africa CDC-Led MpOx Therapeut...
Source: Addis Ababa, Ethiopia And Kinshasa, Democratic Republic Of The Congo And Washington And Paris
Dec 30, 2024 @ 10:26 PM
Why Emergent BioSolutions Stock Blasted Higher Tod...
Source: Eric Volkman
Dec 9, 2024 @ 4:30 PM
War On Drugs 'Has Failed, Completely And Utterly':...
Source: Maureen Meehan
Dec 3, 2024 @ 11:47 PM
Why Emergent BioSciences Stock Plummeted Today
Source: Eric Volkman
Oct 25, 2024 @ 1:00 PM
Pomerantz LLP Announces Proposed Class Action Sett...
Source: Pomerantz Llp
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $-3.93 $2.16 $-5.38
Diluted EPS $-4.03 $2.06 $-5.38
Revenue $ 1.13B $ 293.8M $ 254.7M
Gross Profit $ 345.8M $ 161.2M $ -48M
Net Income / Loss $ -208.8M $ 114.8M $ -283.1M
Operating Income / Loss $ -143M $ 64.5M $ -203.5M
Cost of Revenue $ 748.4M $ 122.6M $ 296.1M
Net Cash Flow $ 68.6M $ 85.4M $ -8M
PE Ratio